Pharmacy Author: Omudhome Ogbru, PharmD Omudhome Ogbru, PharmD Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University ... MedicineNet.com, 4 days ago
New and Generic Drug Approvals: Zegerid Otc - U.S. Food and Drug Administration, 3 weeks ago
Posted by admin on June 27, 2015 Chrissy Teigen loves John Legend—this is definitely an disputed proven fact that we have all arrived at know within this era. However that does not mean the Grammy- and Oscar-winning music performer is not ...NewsListOnline, 1 week ago
ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy
First programme to evaluate dual HIV maintenance therapy with dolutegravir and rilpivirine ViiV Healthcare today announced the start of a Phase III clinical trial programme to evaluate the safety and efficacy of dolutegravir (Tivicay®) and ...FierceBiotech, 1 month ago
Salix Pharmaceuticals, Ltd. ( NASDAQ:SLXP ) is scheduled to announce its financial results for the first quarter of fiscal year 2015 (1QFY15) on Thursday, May 7 after the markets close. Analysts are expecting the company to report a significant ...Bidness Etc, 2 months ago
CMS spent $2.5 billion on the heartburn drug in 2013 on 8.2 million claims. Henry Powderly, Managing Editor The Center for Medicare and Medicaid Services spent more than $103 billion on prescription drugs in 2013 under the Medicare Part D ...Healthcare Finance News, 2 months ago
on your WebpageAdd Widget >Get your members hooked!